Search

Your search keyword '"Grassi, Anna"' showing total 397 results

Search Constraints

Start Over You searched for: Author "Grassi, Anna" Remove constraint Author: "Grassi, Anna"
397 results on '"Grassi, Anna"'

Search Results

1. Evolution of the autoresonant plasma wave excitation in two-dimensional particle-in-cell simulations

2. Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience

4. Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial

5. On the control of electron heating for optimal laser radiation pressure ion acceleration

6. Radiation pressure acceleration of high-quality ion beams using ultrashort laser pulses

8. Efficient generation of turbulent collisionless shocks in laser-ablated counter-streaming plasmas

9. Momentum Absorption and Magnetic Field Generation by Obliquely Incident Light

10. Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series

11. Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

12. Perpendicular relativistic shocks in magnetized pair plasma

15. Radiation Pressure Driven Ion Weibel Instability and Collisionless Shocks

16. In situ occurrence and conservation of Beta vulgaris subsp. maritima ((L.) Arcangeli) in Italy.

17. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

18. Vlasov simulation of laser-driven shock acceleration and ion turbulence

22. Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

25. Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

26. Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group

27. Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation

29. Case report: biallelic DNMT3A mutations in acute myeloid leukemia

30. Diagnosis by liver stiffness measurement of sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation: results from the Italian multicentric prospective study (ELASTOVOD)

31. An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants

32. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

34. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19 : An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry

35. Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome

37. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets

38. Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

39. Targeting mitochondrial impairment for the treatment of cardiovascular diseases: from hypertension to ischemia reperfusion injury, searching for new pharmacological targets

42. Carcik-CD19 Cells Expand In Vivo Toward a CD8+ Memory Phenotype and Their Persistence Is Associated with a Longer Duration of Response

43. Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

44. Long-Term Analysis of an Open-Label, Multicentre, Randomized Phase 3 Trial Comparing Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine As a Preparative Regimen for Allogeneic Stem-Cell Transplantation in Patients with Acute Myeloid Leukemia

45. Final Results of Phase I/II Study of Donor-Derived CAR T Cells Engineered with Sleeping Beauty in Pediatric and Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed Post-HSCT

47. Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients

48. Deconstructing SARS‐CoV‐2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD.

50. RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.

Catalog

Books, media, physical & digital resources